Stability of Dabigatran Etexilate in Manufacturer’s Blister Pack Unit-Dose Packaging and Community Pharmacy Blister Pack

摘要

Background:Dabigatran, a direct thrombin inhibitor, is indicated for the prevention and treatment of venous thromboembolism and for stroke prophylaxis in atrial fibrillation. The manufacturer recommends that dabigatran etexilate be retained in the original packaging until administration. Currently, no information exists about the stability of dabigatran etexilate outside its original packaging.